Cutler Group LP Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$170.77 - $211.65 $426,925 - $529,125	2,500 New	2,500 $11,000
Q4 2022 Feb 07, 2023	SELL	$185.53 - $241.31 $315,401 - $410,227	-1,700 Reduced 73.91%	600 $6,000
Q3 2022 Oct 25, 2022	SELL	$138.54 - $232.0 $1.84 Million - $3.09 Million	-13,300 Reduced 85.26%	2,300 $18,000
Q2 2022 Aug 04, 2022	SELL	$120.42 - $169.29 $240,840 - $338,580	-2,000 Reduced 11.36%	15,600 $100,000
Q1 2022 Apr 14, 2022	SELL	$127.18 - $173.91 $203,488 - $278,256	-1,600 Reduced 8.33%	17,600 $220,000
Q4 2021 Jan 18, 2022	BUY	$159.56 - $209.29 $3.06 Million - $4.02 Million	19,200 New	19,200 $58,000
Q3 2021 Oct 26, 2021	SELL	$169.75 - $207.73 $3.84 Million - $4.69 Million	-22,600 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$128.63 - $176.89 $2.91 Million - $4 Million	22,600 New	22,600 $106,000
Q2 2020 Jul 22, 2020	SELL	$104.21 - $156.44 $614,839 - $922,996	-5,900 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$93.12 - $133.99 $242,112 - $348,374	-2,600 Reduced 30.59%	5,900 $22,000
Q4 2019 Feb 06, 2020	BUY	$74.51 - $124.23 $521,570 - $869,610	7,000 Added 466.67%	8,500 $9,000
Q2 2019 Aug 09, 2019	SELL	$65.86 - $92.79 $954,970 - $1.35 Million	-14,500 Reduced 90.63%	1,500 $5,000
Q1 2019 May 10, 2019	BUY	$72.76 - $93.45 $633,012 - $813,015	8,700 Added 119.18%	16,000 $136,000
Q4 2018 Feb 05, 2019	SELL	$62.67 - $88.33 $444,957 - $627,143	-7,100 Reduced 49.31%	7,300 $28,000
Q3 2018 Nov 07, 2018	BUY	$87.52 - $122.67 $743,920 - $1.04 Million	8,500 Added 144.07%	14,400 $65,000
Q2 2018 Aug 10, 2018	SELL	$88.31 - $107.8 $609,339 - $743,820	-6,900 Reduced 53.91%	5,900 $107,000
Q1 2018 May 11, 2018	SELL	$115.92 - $148.54 $1.3 Million - $1.66 Million	-11,200 Reduced 46.67%	12,800 $204,000
Q4 2017 Jan 17, 2018	SELL	$114.49 - $139.98 $17.6 Million - $21.5 Million	-153,900 Reduced 86.51%	24,000 $680,000
Q3 2017 Oct 17, 2017	BUY	$72.53 - $118.27 $12.9 Million - $21 Million	177,900	177,900 $4.61 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.05 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.1 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.22 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account